1. Home
  2. RCUS vs ANDG Comparison

RCUS vs ANDG Comparison

Compare RCUS & ANDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.08

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

ANDG

Andersen Group Inc. Class A Common Stock

N/A

Current Price

$22.90

Market Cap

2.8B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
RCUS
ANDG
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
RCUS
ANDG
Price
$23.08
$22.90
Analyst Decision
Buy
Buy
Analyst Count
9
7
Target Price
$28.89
$29.50
AVG Volume (30 Days)
1.4M
378.3K
Earning Date
02-24-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$240,000,000.00
$810,756,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$45.57
Revenue Growth
N/A
26.86
52 Week Low
$6.50
$20.00
52 Week High
$26.40
$27.51

Technical Indicators

Market Signals
Indicator
RCUS
ANDG
Relative Strength Index (RSI) 52.59 N/A
Support Level $20.70 N/A
Resistance Level $23.40 N/A
Average True Range (ATR) 1.44 0.00
MACD 0.03 0.00
Stochastic Oscillator 61.75 0.00

Price Performance

Historical Comparison
RCUS
ANDG

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About ANDG Andersen Group Inc. Class A Common Stock

Andersen Group Inc is a provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services.

Share on Social Networks: